WO2011084465A3 - Implants and biodegradable fiducial markers - Google Patents

Implants and biodegradable fiducial markers Download PDF

Info

Publication number
WO2011084465A3
WO2011084465A3 PCT/US2010/060474 US2010060474W WO2011084465A3 WO 2011084465 A3 WO2011084465 A3 WO 2011084465A3 US 2010060474 W US2010060474 W US 2010060474W WO 2011084465 A3 WO2011084465 A3 WO 2011084465A3
Authority
WO
WIPO (PCT)
Prior art keywords
implants
biodegradable
fiducial markers
materials
fiducial
Prior art date
Application number
PCT/US2010/060474
Other languages
French (fr)
Other versions
WO2011084465A2 (en
Inventor
Patrick Campbell
Amarpreet S. Sawhney
Original Assignee
Incept, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incept, Llc filed Critical Incept, Llc
Priority to EP10842525.7A priority Critical patent/EP2512540B1/en
Priority to CA2782899A priority patent/CA2782899C/en
Priority to JP2012544750A priority patent/JP5820815B2/en
Priority to EP21203718.8A priority patent/EP3960215A1/en
Priority to CN201080063960.2A priority patent/CN102844054B/en
Priority to EP19185126.0A priority patent/EP3583960A1/en
Priority to IN5177DEN2012 priority patent/IN2012DN05177A/en
Priority to AU2010340067A priority patent/AU2010340067B2/en
Publication of WO2011084465A2 publication Critical patent/WO2011084465A2/en
Publication of WO2011084465A3 publication Critical patent/WO2011084465A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0442—Polymeric X-ray contrast-enhancing agent comprising a halogenated group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0419—Microparticles, microbeads, microcapsules, microspheres, i.e. having a size or diameter higher or equal to 1 micrometer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/18—Materials at least partially X-ray or laser opaque
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Abstract

Implantable materials may be used in an iatrogenic site. Applications include radioopaque materials for fiducial marking.
PCT/US2010/060474 2009-12-15 2010-12-15 Implants and biodegradable fiducial markers WO2011084465A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EP10842525.7A EP2512540B1 (en) 2009-12-15 2010-12-15 Implants and biodegradable fiducial markers
CA2782899A CA2782899C (en) 2009-12-15 2010-12-15 Implants and biodegradable fiducial markers
JP2012544750A JP5820815B2 (en) 2009-12-15 2010-12-15 Implants and biodegradable fiducial markers
EP21203718.8A EP3960215A1 (en) 2009-12-15 2010-12-15 Implants and biodegradable fiducial markers
CN201080063960.2A CN102844054B (en) 2009-12-15 2010-12-15 Implant and the biodegradable fiducial marker of energy
EP19185126.0A EP3583960A1 (en) 2009-12-15 2010-12-15 Implants and biodegradable fiducial markers
IN5177DEN2012 IN2012DN05177A (en) 2009-12-15 2010-12-15
AU2010340067A AU2010340067B2 (en) 2009-12-15 2010-12-15 Implants and biodegradable fiducial markers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28645009P 2009-12-15 2009-12-15
US61/286,450 2009-12-15

Publications (2)

Publication Number Publication Date
WO2011084465A2 WO2011084465A2 (en) 2011-07-14
WO2011084465A3 true WO2011084465A3 (en) 2011-11-17

Family

ID=44143217

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/060474 WO2011084465A2 (en) 2009-12-15 2010-12-15 Implants and biodegradable fiducial markers

Country Status (8)

Country Link
US (11) US8383161B2 (en)
EP (3) EP2512540B1 (en)
JP (1) JP5820815B2 (en)
CN (1) CN102844054B (en)
AU (1) AU2010340067B2 (en)
CA (3) CA2782899C (en)
IN (1) IN2012DN05177A (en)
WO (1) WO2011084465A2 (en)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10675298B2 (en) * 2006-07-27 2020-06-09 Boston Scientific Scimed Inc. Particles
IN2012DN05177A (en) 2009-12-15 2015-10-23 Incept Llc
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
KR20190090048A (en) 2011-12-05 2019-07-31 인셉트, 엘엘씨 Medical organogel processes and compositions
CA2861048C (en) * 2012-01-24 2021-01-12 Lifecell Corporation Elongated tissue matrices
CN104303184B (en) * 2012-03-21 2018-05-15 皇家飞利浦有限公司 Integrate the Clinical workstations of imaging of medical and biopsy data and use its method
US9220807B2 (en) * 2012-11-04 2015-12-29 Miba Medical Inc. Non-toxic cross-linker for hyaluronic acid
US9226797B2 (en) * 2012-11-04 2016-01-05 Miba Medical Inc. Computer aided implantation of body implants
WO2014145397A1 (en) * 2013-03-15 2014-09-18 Herskovic Arnold M Device and method for delivering medicaments
CN105517580A (en) * 2013-03-15 2016-04-20 马修·R·德勒埃 Imageable embolic microsphere
MX2015016155A (en) * 2013-05-24 2016-08-19 Univ Danmarks Tekniske Gel formulations for guiding radiotherapy.
EA201690050A1 (en) 2013-06-20 2016-05-31 Нанобиотикс COMPOSITIONS AND METHODS FOR USE IN MEDICAL DIAGNOSTICS
PL3010552T3 (en) * 2013-06-20 2019-09-30 Nanobiotix Compositions for use in oncology
US10842969B2 (en) 2013-10-25 2020-11-24 Mercator Medsystems, Inc. Systems and methods of treating malacia by local delivery of hydrogel to augment tissue
US20210338267A1 (en) * 2014-04-03 2021-11-04 Corbin Clinical Resources, Llc Transperineal prostate biopsy and treatment methods
US10022475B2 (en) * 2014-05-01 2018-07-17 Bao Tran Body augmentation device
US9561095B1 (en) * 2015-10-12 2017-02-07 Phi Nguyen Body augmentation device
US9636210B2 (en) 2014-05-19 2017-05-02 Mentor Worldwide Llc Injection zone markers for biomedical implants
US9678022B2 (en) * 2014-09-05 2017-06-13 The Boeing Company Nonaqueous radiopaque fluid and associated imaging system and method
KR101555358B1 (en) * 2014-10-21 2015-09-24 사회복지법인 삼성생명공익재단 A Biocompatible Fiducial Marker Using Multi-block Copolymers
WO2016065245A1 (en) 2014-10-24 2016-04-28 Incept, Llc Extra luminal scaffold
JP7092502B2 (en) 2014-12-10 2022-06-28 インセプト・リミテッド・ライアビリティ・カンパニー Hydrogel drug delivery implant
AU2015362621B2 (en) 2014-12-15 2019-01-17 The Johns Hopkins University Sunitinib formulations and methods for use thereof in treatment of ocular disorders
CN107921237A (en) 2015-04-27 2018-04-17 反射医学公司 Sympathetic nerve cardiopulmonary neural modulation system and method
EP3294212B1 (en) 2015-05-12 2023-10-25 Incept, LLC Drug delivery from hydrogels
NZ738527A (en) 2015-05-28 2022-07-01 Nanobiotix Nanoparticles for use as a therapeutic vaccine
US20170103184A1 (en) * 2015-10-12 2017-04-13 Phi Nguyen Injectable filler
CN114469872A (en) 2015-11-12 2022-05-13 灰色视觉公司 Aggregate microparticles for therapy
US20170136144A1 (en) 2015-11-12 2017-05-18 John C. Herr Compositions and methods for vas-occlusive contraception
KR20180086468A (en) 2015-11-25 2018-07-31 인셉트, 엘엘씨 Shape-deformed drug delivery device and method
US11246879B2 (en) 2016-02-09 2022-02-15 Tulai Therapeutics, Inc. Methods, agents, and devices for local neuromodulation of autonomic nerves
AU2017290353B2 (en) 2016-06-29 2023-05-18 Tulavi Therapeutics, Inc. Treatment of sepsis and related inflammatory conditions by local neuromodulation of the autonomic nervous system
WO2018009839A1 (en) * 2016-07-07 2018-01-11 University Of Virginia Patent Foundation Thiol-michael addition hydrogel-based brachytherapy system and methods comprising the same
CN106334213B (en) * 2016-08-31 2019-07-26 安疗生命科学（武汉）有限公司 A kind of vascular suppository material, preparation method and the purposes in medicine preparation
KR102520771B1 (en) 2016-09-23 2023-04-12 인셉트, 엘엘씨 Drug delivery depot in the anterior chamber
ES2905695T3 (en) * 2016-11-23 2022-04-11 Hologic Inc biopsy site marker
US10751124B2 (en) 2017-01-05 2020-08-25 Contraline, Inc. Methods for implanting and reversing stimuli-responsive implants
US20180289467A1 (en) * 2017-04-05 2018-10-11 Ernesto Andrade Dispensing device, kit, and method for tissue augmentation
US11160870B2 (en) 2017-05-10 2021-11-02 Graybug Vision, Inc. Extended release microparticles and suspensions thereof for medical therapy
CN107307922A (en) * 2017-07-06 2017-11-03 刘志光 The preparation method that a kind of human body is implanted into filler particles
CA3063913A1 (en) * 2017-07-07 2019-01-10 Shadwell Endoscopic, Inc. System and method for marking and subsequently locating sites of biopsies using rfid technology
JP2020536955A (en) 2017-10-06 2020-12-17 ファウンドリー セラピューティクス， インコーポレイテッド Implantable depot for controlled release of therapeutic agent
US10426424B2 (en) 2017-11-21 2019-10-01 General Electric Company System and method for generating and performing imaging protocol simulations
CN111902165A (en) 2018-03-07 2020-11-06 马金-克利尔私人有限公司 Local brachytherapy device and method of treating malignant cancer cells
BR112020023399A2 (en) 2018-05-15 2021-02-09 Incept, Llc embolic compositions and methods
WO2020010164A1 (en) 2018-07-02 2020-01-09 Corinne Bright Methods and devices for in situ formed nerve cap
WO2020056369A1 (en) 2018-09-13 2020-03-19 Allergan, Inc. Tissue expansion device
USD896383S1 (en) 2018-09-13 2020-09-15 Allergan, Inc. Tissue expansion device
US11318040B2 (en) 2018-11-13 2022-05-03 Contraline, Inc. Systems and methods for delivering biomaterials
CA3138695A1 (en) * 2019-05-03 2020-11-12 Palette Life Sciences, Inc. Improved tissue spacers
EP3983340B1 (en) * 2019-06-12 2023-08-02 Nouryon Chemicals International B.V. Method for isolating carboxylic acid from an aqueous side stream
US11820868B2 (en) 2019-08-28 2023-11-21 Boston Scientific Scimed, Inc. Multifunctional nitroxide-mediated polymerization initiators and multi-armed polymers and hydrogels formed therefrom
US11807720B2 (en) 2019-08-28 2023-11-07 Boston Scientific Scimed, Inc. Multi-armed polyoxazolines and compositions, systems and methods pertaining to the same
EP3965842A1 (en) 2019-08-28 2022-03-16 Boston Scientific Scimed, Inc. Medical compositions based on crosslinkable hydrophilic polymers
WO2021041225A1 (en) 2019-08-28 2021-03-04 Boston Scientific Scimed, Inc. Multi-armed polymers comprising free-radical-polymerizable monomers
WO2021145325A1 (en) * 2020-01-14 2021-07-22 持田製薬株式会社 Combination and method for treating subject using alginic acid salt
CN111905155B (en) * 2020-07-23 2021-10-15 北京诺康达医药科技股份有限公司 Closed hydrogel and preparation method and application thereof
WO2023076152A1 (en) 2021-10-25 2023-05-04 Boston Scientific Scimed Inc. Iodine labeled hydrogels and precursors thereof with improved radiopacity
WO2023136639A1 (en) * 2022-01-13 2023-07-20 국립암센터 Biocompatible composition for labeling target lesion, and preparation method therefor
US20230241295A1 (en) 2022-02-02 2023-08-03 Boston Scientific Scimed, Inc. Iodinated compounds and hydrogels formed from same
CN114344554A (en) * 2022-02-11 2022-04-15 上海益思妙医疗器械有限公司 Application of PEG compound in preparation of embolic agent
US11701451B1 (en) 2022-03-11 2023-07-18 Carbon Medical Technologies, Inc. Soft tissue filler and methods
WO2023230267A1 (en) * 2022-05-25 2023-11-30 Cedars-Sinai Medical Center Microgel-encapsulated ipsc-derived notochordal cells for treatment of intervertebral disc degeneration and discogenic pain
US20240076266A1 (en) 2022-08-17 2024-03-07 Boston Scientific Scimed, Inc. Iodine labeled hydrogels and precursors thereof with improved properties

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514379A (en) * 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
US6060534A (en) * 1996-07-11 2000-05-09 Scimed Life Systems, Inc. Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
US6475477B1 (en) * 1997-11-07 2002-11-05 Rutgers, The State University Radio-opaque polymer biomaterials
US20040133275A1 (en) * 2000-03-27 2004-07-08 Mansmann Kevin A. Implants for replacing cartilage, with negatively-charged hydrogel surfaces and flexible matrix reinforcement
US20070264227A1 (en) * 2001-11-07 2007-11-15 Eidgenossische Technische Hochschule Zurich Synthetic Matrix for Controlled Cell Ingrowth and Tissue Regeneration

Family Cites Families (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640741A (en) 1970-02-24 1972-02-08 Hollister Inc Composition containing gel
US3865108A (en) 1971-05-17 1975-02-11 Ortho Pharma Corp Expandable drug delivery device
US3872856A (en) 1971-06-09 1975-03-25 Ralph S Clayton Apparatus for treating the walls and floor of the pelvic cavity with radiation
US4002173A (en) 1974-07-23 1977-01-11 International Paper Company Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
DE2437629C3 (en) 1974-08-05 1978-09-21 Basf Ag, 6700 Ludwigshafen Process for the preparation of insoluble polymers of N-vinyllactams which are only slightly swellable in water
US4014335A (en) 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US4193813A (en) 1976-09-07 1980-03-18 Medi-Coll, Inc. Method for making collagen sponge
US4207893A (en) 1977-08-29 1980-06-17 Alza Corporation Device using hydrophilic polymer for delivering drug to biological environment
CA1295796C (en) 1984-03-27 1992-02-18 Conrad Whyne Biodegradable matrix and methods for producing same
US4697575A (en) 1984-11-21 1987-10-06 Henry Ford Hospital Delivery system for interstitial radiation therapy including substantially non-deflecting elongated member
US4714074A (en) 1985-06-28 1987-12-22 Centre National De La Recherche Scientifique Method for protecting human or animal organs against radiation
US5160745A (en) 1986-05-16 1992-11-03 The University Of Kentucky Research Foundation Biodegradable microspheres as a carrier for macromolecules
US4741872A (en) 1986-05-16 1988-05-03 The University Of Kentucky Research Foundation Preparation of biodegradable microspheres useful as carriers for macromolecules
IL82834A (en) 1987-06-09 1990-11-05 Yissum Res Dev Co Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5306500A (en) 1988-11-21 1994-04-26 Collagen Corporation Method of augmenting tissue with collagen-polymer conjugates
US5162430A (en) 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5304595A (en) 1988-11-21 1994-04-19 Collagen Corporation Collagen-polymer conjugates
US5550187A (en) 1988-11-21 1996-08-27 Collagen Corporation Method of preparing crosslinked biomaterial compositions for use in tissue augmentation
IL90193A (en) 1989-05-04 1993-02-21 Biomedical Polymers Int Polurethane-based polymeric materials and biomedical articles and pharmaceutical compositions utilizing the same
US5324519A (en) 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5410016A (en) 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5529914A (en) 1990-10-15 1996-06-25 The Board Of Regents The Univeristy Of Texas System Gels for encapsulation of biological materials
CA2094908C (en) 1990-12-06 2000-02-08 Byron Kent Hayes Implantable bioabsorbable article
FR2672713A1 (en) * 1991-02-13 1992-08-14 Inst Nat Polytech Grenoble FEEDING COMPONENT OF THE CREDIT CARD TYPE.
US5629008A (en) 1992-06-02 1997-05-13 C.R. Bard, Inc. Method and device for long-term delivery of drugs
US6592859B1 (en) 1992-08-20 2003-07-15 Ethicon, Inc. Controlled expansion sphincter augmentation media
DK0659073T3 (en) 1992-09-10 2002-03-11 Childrens Medical Center Biodegradable polymer matrices with sustained release of local anesthetics
ATE169483T1 (en) 1993-04-28 1998-08-15 Focal Inc APPARATUS, PRODUCT AND USE RELATING TO INTRALUMINAL PHOTOTHERMOFORMING
US5565215A (en) * 1993-07-23 1996-10-15 Massachusettes Institute Of Technology Biodegradable injectable particles for imaging
US5499994A (en) 1993-07-30 1996-03-19 American Medical Systems, Inc. Dilation device for the urethra
DE4414755C2 (en) 1994-04-27 2000-11-16 Lohmann Therapie Syst Lts Collagen preparation for the controlled delivery of active ingredients, processes and use
CA2188464C (en) 1994-04-27 2006-08-08 Michael Roreger Collagen preparation for the controlled release of active substances
JP4209941B2 (en) 1995-03-23 2009-01-14 ジェンザイム・コーポレーション Undercoat redox and photoinitiator systems for improved adhesion of gels to substrates
US5900245A (en) 1996-03-22 1999-05-04 Focal, Inc. Compliant tissue sealants
US6214331B1 (en) 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US5855915A (en) 1995-06-30 1999-01-05 Baylor University Tablets or biologically acceptable implants for long-term antiinflammatory drug release
ATE342295T1 (en) 1995-07-28 2006-11-15 Genzyme Corp BIODEGRADABLE MULTIBLOKHYDROGENS AND THEIR USE AS CARRIERS FOR CONTROLLED RELEASE PHARMACOLOGICALLY ACTIVE MATERIALS AND TISSUE CONTACT MATERIALS
US5759583A (en) 1995-08-30 1998-06-02 Syntex (U.S.A.) Inc. Sustained release poly (lactic/glycolic) matrices
US5733316A (en) 1995-10-27 1998-03-31 Dornier Medical Systems, Inc. Organ separation for thermal therapy
US5863984A (en) 1995-12-01 1999-01-26 Universite Laval, Cite Universitaire Biostable porous material comprising composite biopolymers
EP1704878B1 (en) 1995-12-18 2013-04-10 AngioDevice International GmbH Crosslinked polymer compositions and methods for their use
US5752974A (en) 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
US7049346B1 (en) 1996-08-20 2006-05-23 Menlo Care Div Of Ethicon, Inc. Swollen hydrogel for sphincter augmentation
US6063061A (en) 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US20020064546A1 (en) * 1996-09-13 2002-05-30 J. Milton Harris Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
US7009034B2 (en) 1996-09-23 2006-03-07 Incept, Llc Biocompatible crosslinked polymers
ZA978537B (en) 1996-09-23 1998-05-12 Focal Inc Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
AU4648697A (en) 1996-09-23 1998-04-14 Chandrashekar Pathak Methods and devices for preparing protein concentrates
US6214966B1 (en) 1996-09-26 2001-04-10 Shearwater Corporation Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
US5932539A (en) 1996-10-15 1999-08-03 The Board Of Trustees Of The University Of Illinois Biodegradable polymer matrix for tissue repair
JP3092530B2 (en) 1996-11-05 2000-09-25 日本油脂株式会社 Method for producing imidyl succinate-substituted polyoxyalkylene derivative
JP3092531B2 (en) 1996-11-05 2000-09-25 日本油脂株式会社 Method for producing imidyl succinate-substituted polyoxyalkylene derivative
US6371975B2 (en) 1998-11-06 2002-04-16 Neomend, Inc. Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers
US6224893B1 (en) 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
US6271278B1 (en) 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
IL121861A (en) 1997-09-29 2003-07-31 Moshe Ein Gal Prostate radiotherapy apparatus
US8288745B2 (en) 1997-10-10 2012-10-16 Senorx, Inc. Method of utilizing an implant for targeting external beam radiation
JP2001519203A (en) 1997-10-10 2001-10-23 ジョン・ディ・コービット・ジュニア Breast implant
CA2305349A1 (en) 1997-10-27 1999-05-06 Alexander R. Irvine Methods and pharmaceutical compositions for the closure of retinal breaks
US6375634B1 (en) 1997-11-19 2002-04-23 Oncology Innovations, Inc. Apparatus and method to encapsulate, kill and remove malignancies, including selectively increasing absorption of x-rays and increasing free-radical damage to residual tumors targeted by ionizing and non-ionizing radiation therapy
US6660301B1 (en) 1998-03-06 2003-12-09 Biosphere Medical, Inc. Injectable microspheres for dermal augmentation and tissue bulking
US6428978B1 (en) 1998-05-08 2002-08-06 Cohesion Technologies, Inc. Methods for the production of gelatin and full-length triple helical collagen in recombinant cells
US6066856A (en) 1998-05-18 2000-05-23 Children's Medical Center Corporation Radiation protective device
US6280742B1 (en) * 1998-06-17 2001-08-28 Zonagen, Inc. Methods and materials for the treatment of prostatic carcinoma
US6206930B1 (en) 1998-08-10 2001-03-27 Charlotte-Mecklenburg Hospital Authority Absorbable tissue expander
EP1104324B8 (en) 1998-08-14 2011-06-22 Incept Llc Apparatus for in situ formation of hydrogels
US6632457B1 (en) 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
US6514534B1 (en) 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
US6605294B2 (en) 1998-08-14 2003-08-12 Incept Llc Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
US6152943A (en) 1998-08-14 2000-11-28 Incept Llc Methods and apparatus for intraluminal deposition of hydrogels
US6818018B1 (en) 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
US6703047B2 (en) 2001-02-02 2004-03-09 Incept Llc Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
US6179862B1 (en) 1998-08-14 2001-01-30 Incept Llc Methods and apparatus for in situ formation of hydrogels
PT1124546E (en) 1998-10-22 2004-08-31 Bioniche Life Sciences Inc A METHOD FOR PREVENTING REDUCING AND TREATING CYSTITIS USING HYALURONIC ACID
US6899889B1 (en) 1998-11-06 2005-05-31 Neomend, Inc. Biocompatible material composition adaptable to diverse therapeutic indications
US8802146B2 (en) 1998-11-06 2014-08-12 Neomend, Inc. Systems, methods, and compositions for prevention of tissue adhesion
WO2000028919A1 (en) 1998-11-12 2000-05-25 Canadian Prostate Centre, Inc. Apparatus and method of separating organs to enable aggressive thermal therapy
US6110484A (en) 1998-11-24 2000-08-29 Cohesion Technologies, Inc. Collagen-polymer matrices with differential biodegradability
US20080114092A1 (en) 1998-12-04 2008-05-15 Incept Llc Adhesion barriers applicable by minimally invasive surgery and methods of use thereof
JP2002531217A (en) 1998-12-04 2002-09-24 チャンドラシェカー ピー． パサック， Biocompatible crosslinked polymer
TW392930U (en) * 1998-12-28 2000-06-01 Hon Hai Prec Ind Co Ltd Electric connector
US6958212B1 (en) 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
US6862470B2 (en) 1999-02-02 2005-03-01 Senorx, Inc. Cavity-filling biopsy site markers
KR100845769B1 (en) * 1999-02-03 2008-07-11 파우더젝트 리서치 리미티드 Hydrogel Particle Formulations
US6177514B1 (en) 1999-04-09 2001-01-23 Sulzer Carbomedics Inc. Blocked functional reagants for cross-linking biological tissues
CA2368617C (en) 1999-04-12 2010-03-16 Cornell Research Foundation, Inc. Hydrogel-forming system with hydrophobic and hydrophilic components
US6268405B1 (en) 1999-05-04 2001-07-31 Porex Surgical, Inc. Hydrogels and methods of making and using same
US6426145B1 (en) 1999-05-20 2002-07-30 Scimed Life Systems, Inc. Radiopaque compositions for visualization of medical devices
US6428785B1 (en) 1999-10-28 2002-08-06 Immunolytics Inc. Method and composition for treating prostate cancer
AU1658601A (en) 1999-11-15 2001-05-30 The Texas A & M University System Wound sealant formed in situ
US6479079B1 (en) 1999-12-13 2002-11-12 Sulzer Carbomedics Inc. Anticalcification treatments for fixed biomaterials
US6436424B1 (en) 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
ES2391763T3 (en) 2000-04-07 2012-11-29 Collagen Matrix, Inc. Embolization device
US6599448B1 (en) 2000-05-10 2003-07-29 Hydromer, Inc. Radio-opaque polymeric compositions
US6383344B1 (en) 2000-07-19 2002-05-07 Genzyme Corporation Molecular weight reduction of polymer using irradiation treatment
US6545097B2 (en) 2000-12-12 2003-04-08 Scimed Life Systems, Inc. Drug delivery compositions and medical devices containing block copolymer
US6596471B2 (en) 2000-12-21 2003-07-22 Carbomedics Inc. Method of cross-linking tissue with a bis-maleimide compound
CA2438193A1 (en) 2001-02-26 2002-09-06 Duke University Novel dendritic polymers and their biomedical uses
JP4123856B2 (en) 2001-07-31 2008-07-23 日油株式会社 Bio-related substance modifier and method for producing polyoxyalkylene derivative
KR20040041660A (en) 2001-10-03 2004-05-17 다이니혼 죠츄기쿠 가부시키가이샤 Propargyl benzyl alcohol ester derivative, method for producing the same, and insecticidal and moth proofing agent containing the same
US20040131582A1 (en) 2002-02-26 2004-07-08 Grinstaff Mark W. Novel dendritic polymers and their biomedical uses
US7341716B2 (en) * 2002-04-12 2008-03-11 Boston Scientific Scimed, Inc. Occlusive composition
WO2004000103A2 (en) * 2002-06-24 2003-12-31 Noyes William R Fillers and methods for displacing tissues to improve radiological outcomes
US7351430B2 (en) 2002-11-06 2008-04-01 Uluru Inc. Shape-retentive hydrogel particle aggregates and their uses
US7129210B2 (en) 2003-07-23 2006-10-31 Covalent Medical, Inc. Tissue adhesive sealant
US20050033157A1 (en) * 2003-07-25 2005-02-10 Klein Dean A. Multi-modality marking material and method
US7790141B2 (en) * 2003-08-11 2010-09-07 Pathak Holdings, Llc Radio-opaque compounds, compositions containing same and methods of their synthesis and use
EP1673109B1 (en) 2003-09-25 2019-03-20 Rutgers, The State University of New Jersey Inherently radiopaque polymeric products for embolotherapy
EP1763320B8 (en) 2004-06-23 2020-01-01 Bioprotect Ltd. Device for tissue displacement or separation
FR2872262B1 (en) 2004-06-29 2010-11-26 Air Liquide METHOD AND INSTALLATION FOR PROVIDING SUPPORT OF A PRESSURIZED GAS
WO2006020616A1 (en) 2004-08-13 2006-02-23 Reva Medical, Inc. Inherently radiopaque bioresorbable polymers for multiple uses
WO2006031358A2 (en) 2004-08-13 2006-03-23 Hyperbranch Medical Technology, Inc. Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses
WO2006031388A2 (en) 2004-08-20 2006-03-23 Hyperbranch Medical Technology, Inc. Dentritic polymers, crosslinked gels, and their uses in orthopedic applications
US7919112B2 (en) 2004-08-26 2011-04-05 Pathak Holdings, Llc Implantable tissue compositions and method
WO2006078770A2 (en) 2005-01-21 2006-07-27 Civco Medical Instruments Co., Inc. Creating temporary space between body tissues
WO2007001926A2 (en) 2005-06-24 2007-01-04 Hyperbranch Medical Technology, Inc. Low-swelling hydrogel sealants for wound repair
WO2007005249A2 (en) 2005-06-29 2007-01-11 Hyperbranch Medical Technology, Inc. Nanoparticles and dendritic-polymer-based hydrogels comprising them
DE102005051366A1 (en) * 2005-10-25 2007-04-26 Degussa Gmbh Drug delivery systems
EP1996243B1 (en) 2006-01-11 2014-04-23 HyperBranch Medical Technology, Inc. Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices
US8795709B2 (en) 2006-03-29 2014-08-05 Incept Llc Superabsorbent, freeze dried hydrogels for medical applications
US7597882B2 (en) 2006-04-24 2009-10-06 Incept Llc Protein crosslinkers, crosslinking methods and applications thereof
US7872068B2 (en) 2006-05-30 2011-01-18 Incept Llc Materials formable in situ within a medical device
AU2008214319A1 (en) 2007-02-06 2008-08-14 Incept, Llc Polymerization with precipitation of proteins for elution in physiological solution
WO2008101173A2 (en) 2007-02-16 2008-08-21 Cornell University Biodegradable compositions and materials
US20080220047A1 (en) 2007-03-05 2008-09-11 Sawhney Amarpreet S Low-swelling biocompatible hydrogels
US9987221B2 (en) 2007-08-23 2018-06-05 Boston Scientific Scimed, Inc. Injectable hydrogel compositions
CA2707649A1 (en) 2007-11-02 2009-05-07 Genzyme Corporation Methods of augmenting or repairing soft tissue
JP5739668B2 (en) * 2008-02-13 2015-06-24 ハイパーブランチ メディカル テクノロジー， インコーポレイテッド Crosslinked polyalkyleneimine hydrogels with adjustable degradation rate
CN101724144A (en) 2008-11-03 2010-06-09 北京键凯科技有限公司 Novel multi-arm polyethylene glycol, preparation method and application thereof
BRPI0921791B1 (en) 2008-11-03 2018-10-30 Univ Cornell use of a material comprising poly (ethylene glycol) / polyhydroxyacetone (peg-pdha) copolymer in the manufacture of medicaments
IN2012DN05177A (en) 2009-12-15 2015-10-23 Incept Llc
US8734930B2 (en) 2010-05-27 2014-05-27 Covidien Lp Hydrogel implants with varying degrees of crosslinking
JP2016508536A (en) 2013-02-08 2016-03-22 エンドゥーシェイプ インコーポレイテッド Radiopaque polymers for medical devices
US9789073B2 (en) 2013-03-14 2017-10-17 Pathak Holdings, Llc Compositions, methods and devices for local drug delivery
CN107759783A (en) 2013-12-02 2018-03-06 北京键凯科技股份有限公司 Alkynyl multi-arm polyethylene glycol derivative
CN106146325B (en) 2015-04-24 2019-01-29 北京键凯科技股份有限公司 A kind of Y type multicondensed ethylene glycol derivative and preparation method thereof
WO2019053269A1 (en) * 2017-09-15 2019-03-21 Université De Strasbourg Injectable hybrid alginate hydrogels and uses thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514379A (en) * 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
US6060534A (en) * 1996-07-11 2000-05-09 Scimed Life Systems, Inc. Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
US6475477B1 (en) * 1997-11-07 2002-11-05 Rutgers, The State University Radio-opaque polymer biomaterials
US20040133275A1 (en) * 2000-03-27 2004-07-08 Mansmann Kevin A. Implants for replacing cartilage, with negatively-charged hydrogel surfaces and flexible matrix reinforcement
US20070264227A1 (en) * 2001-11-07 2007-11-15 Eidgenossische Technische Hochschule Zurich Synthetic Matrix for Controlled Cell Ingrowth and Tissue Regeneration

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DAMIA MAWAD ET AL., BIOMACROMOLECULES, vol. 9, 2008, pages 263 - 264, 268 *

Also Published As

Publication number Publication date
US20110142936A1 (en) 2011-06-16
CN102844054A (en) 2012-12-26
AU2010340067A1 (en) 2012-07-12
CN102844054B (en) 2016-04-20
CA3042067A1 (en) 2011-07-14
IN2012DN05177A (en) 2015-10-23
US10786581B2 (en) 2020-09-29
EP2512540A4 (en) 2013-08-14
US8852646B2 (en) 2014-10-07
US20200206367A1 (en) 2020-07-02
CA3149284A1 (en) 2011-07-14
WO2011084465A2 (en) 2011-07-14
CA2782899C (en) 2019-06-11
US20140363382A1 (en) 2014-12-11
US9308283B2 (en) 2016-04-12
JP5820815B2 (en) 2015-11-24
US20200206365A1 (en) 2020-07-02
US11154624B2 (en) 2021-10-26
EP3960215A1 (en) 2022-03-02
US20210069353A1 (en) 2021-03-11
US20200206366A1 (en) 2020-07-02
US8383161B2 (en) 2013-02-26
CA2782899A1 (en) 2011-07-14
US11083802B2 (en) 2021-08-10
US11786612B2 (en) 2023-10-17
US11160883B2 (en) 2021-11-02
CA3042067C (en) 2022-10-18
US20220125954A1 (en) 2022-04-28
EP3583960A1 (en) 2019-12-25
US20140056816A1 (en) 2014-02-27
US20190201558A1 (en) 2019-07-04
US10272164B2 (en) 2019-04-30
US9669117B2 (en) 2017-06-06
US20160193368A1 (en) 2016-07-07
US20170266324A1 (en) 2017-09-21
EP2512540A2 (en) 2012-10-24
AU2010340067B2 (en) 2015-03-19
JP2013514152A (en) 2013-04-25
EP2512540B1 (en) 2019-08-07

Similar Documents

Publication Publication Date Title
WO2011084465A3 (en) Implants and biodegradable fiducial markers
EP2424427A4 (en) Highly reliable ingestible event markers and methods for using the same
HK1225748A1 (en) Aqueous polyurethaneurea compositions including dispersions and films
EP2195346A4 (en) Dendritic cell marker and uses thereof
PL1973502T3 (en) Stents with radiopaque markers
EP2152205A4 (en) Textile-based surgical implant and related methods
HK1150063A1 (en) Disease markers and uses thereof
AP2770A (en) Materials having embedded insecticides and additives
IL194865A (en) Haloaryl substituted aminopurines and use thereof
JP2010012253A5 (en) Bone anchor with plug member and tool for inserting the plug member into the bone anchor
EP2155039A4 (en) Marker systems and methods of using the same
BRPI0817437A2 (en) Surgical Implant with an Antiretrocess Feature
EP2073754A4 (en) Bioabsorbable polymeric composition and medical device background
EP2139432A4 (en) Deformable implant systems and methods
EP2360203A4 (en) Novel multi-arm polyethylene glycol, preparation method and uses thereof
EP2350985A4 (en) Hidden-code voting and marking systems
DE602007001747D1 (en) Surgical suture with barbs
GB0819602D0 (en) Implant delivery device and method
EP2043554A4 (en) Bioabsorbable polymeric medical device
EP2167144A4 (en) Biopolymer based implantable degradable devices
DE602006002020D1 (en) Antenna system with low height and corresponding procedures
EP2170463A4 (en) Seeds and markers for use in imaging
WO2009099768A3 (en) Biodegradable coatings for implantable medical devices
IL213818A (en) Dipyrromethene-boron hydrophilic fluorescent compounds and uses thereof as fluorescent markers
GB0803074D0 (en) Orthopaedic implants and prostheses

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080063960.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10842525

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2782899

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 5177/DELNP/2012

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2012544750

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2010340067

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2010842525

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2010340067

Country of ref document: AU

Date of ref document: 20101215

Kind code of ref document: A